Andreas Schulte‐Mecklenbeck

2.7k total citations · 1 hit paper
53 papers, 1.3k citations indexed

About

Andreas Schulte‐Mecklenbeck is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Andreas Schulte‐Mecklenbeck has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 19 papers in Immunology and 16 papers in Neurology. Recurrent topics in Andreas Schulte‐Mecklenbeck's work include Multiple Sclerosis Research Studies (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (16 papers) and Peripheral Neuropathies and Disorders (8 papers). Andreas Schulte‐Mecklenbeck is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Neuroinflammation and Neurodegeneration Mechanisms (16 papers) and Peripheral Neuropathies and Disorders (8 papers). Andreas Schulte‐Mecklenbeck collaborates with scholars based in Germany, United States and United Kingdom. Andreas Schulte‐Mecklenbeck's co-authors include Heinz Wiendl, Catharina C. Groß, Sven G. Meuth, Luisa Klotz, Gerd Meyer zu Hörste, Anita Posevitz‐Fejfár, Tanja Kuhlmann, Michael Heming, Jolien Wolbert and Nicholas Schwab and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neurology.

In The Last Decade

Andreas Schulte‐Mecklenbeck

49 papers receiving 1.3k citations

Hit Papers

Integrated single cell analysis of blood and cerebrospina... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis
    2020 256 citations David Schafflick, Chenling Xu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Schulte‐Mecklenbeck Germany 19 630 435 282 270 217 53 1.3k
Annet F. Wierenga‐Wolf Netherlands 21 750 1.2× 475 1.1× 367 1.3× 287 1.1× 158 0.7× 39 1.5k
Peter J. Darlington Canada 18 753 1.2× 463 1.1× 257 0.9× 447 1.7× 146 0.7× 35 1.6k
Marvin M. van Luijn Netherlands 18 571 0.9× 434 1.0× 190 0.7× 223 0.8× 148 0.7× 43 1.1k
Ellen Iacobaeus Sweden 17 443 0.7× 783 1.8× 138 0.5× 268 1.0× 281 1.3× 32 1.5k
Philippe Saikali Canada 15 621 1.0× 704 1.6× 315 1.1× 360 1.3× 465 2.1× 18 1.5k
Christian Schläger Germany 6 606 1.0× 277 0.6× 589 2.1× 221 0.8× 95 0.4× 8 1.3k
Lars Börnsen Denmark 18 487 0.8× 752 1.7× 133 0.5× 270 1.0× 265 1.2× 32 1.3k
V. Navikas Sweden 16 667 1.1× 417 1.0× 236 0.8× 184 0.7× 151 0.7× 24 1.2k
Ian Sutton Australia 20 542 0.9× 363 0.8× 135 0.5× 352 1.3× 814 3.8× 43 2.0k
Anne Cotleur United States 14 563 0.9× 265 0.6× 456 1.6× 201 0.7× 117 0.5× 20 1.2k

Countries citing papers authored by Andreas Schulte‐Mecklenbeck

Since Specialization
Citations

This map shows the geographic impact of Andreas Schulte‐Mecklenbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schulte‐Mecklenbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schulte‐Mecklenbeck more than expected).

Fields of papers citing papers by Andreas Schulte‐Mecklenbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Schulte‐Mecklenbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schulte‐Mecklenbeck. The network helps show where Andreas Schulte‐Mecklenbeck may publish in the future.

Co-authorship network of co-authors of Andreas Schulte‐Mecklenbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schulte‐Mecklenbeck. A scholar is included among the top collaborators of Andreas Schulte‐Mecklenbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schulte‐Mecklenbeck. Andreas Schulte‐Mecklenbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eveslage, Maria, Andreas Schulte‐Mecklenbeck, Catharina C. Groß, et al.. (2025). Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab. Multiple Sclerosis Journal. 31(7). 813–820.
2.
Schneider‐Hohendorf, Tilman, Andreas Schulte‐Mecklenbeck, Catarina Rapôso, et al.. (2025). B- and T cell receptor sequencing elucidates characteristics of lymphocyte depletion by ocrelizumab. iScience. 28(8). 113068–113068.
3.
Schulte‐Mecklenbeck, Andreas, et al.. (2024). Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy. Cell Reports Medicine. 5(7). 101622–101622. 5 indexed citations
4.
Heming, Michael, Tobias Brix, Andreas Schulte‐Mecklenbeck, et al.. (2024). Severe CSF immune cell alterations in cryptococcal meningitis gradually resolve during antifungal therapy. BMC Neurology. 24(1). 229–229. 1 indexed citations
5.
Heming, Michael, Leoni Rolfes, Andreas Schulte‐Mecklenbeck, et al.. (2023). Supporting the differential diagnosis of connective tissue diseases with neurological involvement by blood and cerebrospinal fluid flow cytometry. Journal of Neuroinflammation. 20(1). 46–46. 4 indexed citations
6.
Sauer, R, Andreas Schulte‐Mecklenbeck, Catharina C. Groß, et al.. (2023). Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report. Therapeutic Advances in Neurological Disorders. 16. 4223470411–4223470411.
7.
Beuker, Carolin, Nadine Bonberg, Jan‐Kolja Strecker, et al.. (2023). Stroke in Patients with Bacterial Meningitis: A Cohort Study and Meta‐Analysis. Annals of Neurology. 93(6). 1094–1105. 6 indexed citations
8.
Heming, Michael, Jolien Wolbert, I‐Na Lu, et al.. (2022). Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma. Genome Medicine. 14(1). 109–109. 28 indexed citations
9.
Schulte‐Mecklenbeck, Andreas, Timo Wirth, Manfred Fobker, et al.. (2022). Impact of disease‐modifying therapies on humoral and cellular immune‐responses following SARS‐CoV‐2 vaccination in MS patients. Clinical and Translational Science. 15(7). 1606–1612. 3 indexed citations
10.
Wölfer, Johannes, Markus Holling, Benjamin Brokinkel, et al.. (2022). Blockade of inhibitory killer cell immunoglobulin-like receptors and IL-2 triggering reverses the functional hypoactivity of tumor-derived NK-cells in glioblastomas. Scientific Reports. 12(1). 6769–6769. 13 indexed citations
11.
Beuker, Carolin, Christian Thomas, Jan‐Kolja Strecker, et al.. (2021). Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype. Annals of Neurology. 90(1). 118–129. 14 indexed citations
12.
Rolfes, Leoni, Andreas Schulte‐Mecklenbeck, Stefanie Schreiber, et al.. (2021). Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Communications. 3(3). fcab157–fcab157. 23 indexed citations
13.
Eschborn, Melanie, Marc Pawlitzki, Timo Wirth, et al.. (2021). Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 8(6). 37 indexed citations
14.
Schafflick, David, Chenling Xu, Michael B. Cole, et al.. (2020). Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nature Communications. 11(1). 247–247. 256 indexed citations breakdown →
15.
Ruck, Tobias, Andreas Schulte‐Mecklenbeck, Steffen Pfeuffer, et al.. (2019). Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study. EBioMedicine. 46. 381–386. 12 indexed citations
16.
Liebmann, Marie, Claudia Janoschka, Alexander M. Herrmann, et al.. (2018). Dimethyl Fumarate Treatment alters T Cell Metabolism in Multiple Sclerosis (P1.414). Neurology. 90(15_supplement). 1 indexed citations
17.
18.
Ruland, Tillmann, Jolien Wolbert, Michael G. Gottschalk, et al.. (2018). Cerebrospinal Fluid Concentrations of Neuronal Proteins Are Reduced in Primary Angiitis of the Central Nervous System. Frontiers in Neurology. 9. 407–407. 12 indexed citations
19.
Schulte‐Mecklenbeck, Andreas, Urvashi Bhatia, Tilman Schneider‐Hohendorf, et al.. (2017). Analysis of Lymphocyte Extravasation Using an <em>In Vitro</em> Model of the Human Blood-brain Barrier. Journal of Visualized Experiments. 4 indexed citations
20.
Wiendl, Heinz, Catharina C. Groß, Maren Lindner, et al.. (2016). TERI-DYNAMIC: Exploring the Impact of Teriflunomide on Immune Cell Population Size, Receptor Repertoire, and Function in Patients With RRMS (P5.282). Neurology. 86(16_supplement). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annet F. Wierenga‐Wolf Breakdown of academic impact, for papers by Peter J. Darlington Breakdown of academic impact, for papers by Marvin M. van Luijn Breakdown of academic impact, for papers by Ellen Iacobaeus Breakdown of academic impact, for papers by Philippe Saikali Breakdown of academic impact, for papers by Christian Schläger Breakdown of academic impact, for papers by Lars Börnsen Breakdown of academic impact, for papers by V. Navikas Breakdown of academic impact, for papers by Ian Sutton Breakdown of academic impact, for papers by Anne Cotleur
Rankless by CCL
2026